Ameritas Investment Partners’s ImmunityBio IBRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $307K | Buy |
35,085
+11,128
| +46% | +$84.2K | 0.01% | 1130 |
|
|
2026
Q1 | $184K | Hold |
23,957
| – | – | 0.01% | 1317 |
|
|
2025
Q4 | $47.4K | Buy |
23,957
+4,739
| +25% | +$10.7K | ﹤0.01% | 2160 |
|
|
2025
Q3 | $47.3K | Sell |
19,218
-4,267
| -18% | -$11K | ﹤0.01% | 2171 |
|
|
2025
Q2 | $62K | Buy |
23,485
+9,761
| +71% | +$26.2K | ﹤0.01% | 2058 |
|
|
2025
Q1 | $41.3K | Hold |
13,724
| – | – | ﹤0.01% | 2218 |
|
|
2024
Q4 | $35.1K | Hold |
13,724
| – | – | ﹤0.01% | 2391 |
|
|
2024
Q3 | $51.1K | Hold |
13,724
| – | – | ﹤0.01% | 2180 |
|
|
2024
Q2 | $86.7K | Hold |
13,724
| – | – | ﹤0.01% | 1822 |
|
|
2024
Q1 | $73.7K | Hold |
13,724
| – | – | ﹤0.01% | 1921 |
|
|
2023
Q4 | $68.9K | Buy |
13,724
+2,852
| +26% | +$8.95K | ﹤0.01% | 1969 |
|
|
2023
Q3 | $18.4K | Buy |
10,872
+4,322
| +66% | +$8.68K | ﹤0.01% | 2577 |
|
|
2023
Q2 | $18.2K | Hold |
6,550
| – | – | ﹤0.01% | 2611 |
|
|
2023
Q1 | $11.9K | Hold |
6,550
| – | – | ﹤0.01% | 2670 |
|
|
2022
Q4 | $30.1K | Buy |
6,550
+1,306
| +25% | +$7.17K | ﹤0.01% | 2365 |
|
|
2022
Q3 | $26K | Hold |
5,244
| – | – | ﹤0.01% | 2384 |
|
|
2022
Q2 | $19K | Hold |
5,244
| – | – | ﹤0.01% | 2564 |
|
|
2022
Q1 | $29K | Hold |
5,244
| – | – | ﹤0.01% | 2384 |
|
|
2021
Q4 | $32K | Hold |
5,244
| – | – | ﹤0.01% | 2401 |
|
|
2021
Q3 | $51K | Hold |
5,244
| – | – | ﹤0.01% | 2142 |
|
|
2021
Q2 | $75K | Buy |
5,244
+2,704
| +106% | +$44.7K | ﹤0.01% | 1911 |
|
|
2021
Q1 | $60K | Hold |
2,540
| – | – | ﹤0.01% | 1975 |
|
|
2020
Q4 | $34K | Hold |
2,540
| – | – | ﹤0.01% | 2206 |
|
|
2020
Q3 | $18K | Hold |
2,540
| – | – | ﹤0.01% | 2430 |
|
|
2020
Q2 | $31K | Buy |
+2,540
| New | +$14.3K | ﹤0.01% | 2108 |
|
|
2019
Q2 | – | Sell |
-2,681
| Closed | -$4K | – | 3081 |
|
|
2019
Q1 | $4K | Hold |
2,681
| – | – | ﹤0.01% | 2882 |
|
|
2018
Q4 | $3K | Hold |
2,681
| – | – | ﹤0.01% | 2911 |
|
|
2018
Q3 | $10K | Hold |
2,681
| – | – | ﹤0.01% | 2830 |
|
|
2018
Q2 | $8K | Hold |
2,681
| – | – | ﹤0.01% | 2888 |
|
|
2018
Q1 | $10K | Hold |
2,681
| – | – | ﹤0.01% | 2723 |
|
|
2017
Q4 | $12K | Hold |
2,681
| – | – | ﹤0.01% | 2691 |
|
|
2017
Q3 | $16K | Hold |
2,681
| – | – | ﹤0.01% | 2535 |
|
|
2017
Q2 | $20K | Buy |
2,681
+1,376
| +105% | +$5.94K | ﹤0.01% | 2446 |
|
|
2017
Q1 | $5K | Buy |
+1,305
| New | +$6.45K | ﹤0.01% | 2837 |
|
Other funds holding IBRX
Ameritas Investment Partners's IBRX Position: Q2 2026 in Review
Ameritas Investment Partners increased its ImmunityBio (IBRX) stake by 46% in Q2 2026, buying an estimated $84.2K and bringing the position to 35,085 shares worth $307K. The position accounts for 0.01% of the portfolio, ranked #1130.
Ameritas Investment Partners first reported a position in IBRX in Q1 2017 and has held it in 34 quarters since. 405 funds tracked by Wall St. Rank hold IBRX as of Q2 2026.
- Ameritas Investment Partners held 35,085 shares of ImmunityBio worth $307K as of Q2 2026.
- Ameritas Investment Partners bought 11,128 ImmunityBio shares in Q2 2026, an estimated $84.2K.
- ImmunityBio made up 0.01% of Ameritas Investment Partners's portfolio in Q2 2026, its #1130 holding.
- Ameritas Investment Partners first reported a position in ImmunityBio in Q1 2017 and has held it in 34 quarters since.
- 405 funds tracked by Wall St. Rank held ImmunityBio as of Q2 2026.
Based on Ameritas Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.